Basic Information
Cure51 is a newly established biotechnology company dedicated to unlocking the survival mechanisms of special cancer survivors. At Cure51, our mission is to create the first global database of cancer survivors, utilizing their unique biological characteristics to discover new drugs for cancer treatment. Cure51 brings together talents from diverse professional fields, ranging from bioinformatics to data engineering, biosample analysis, or technical infrastructure, all driven by the same passion: curing cancer.